Results 71 to 80 of about 805 (190)
Endometriosis, a common gynecological disorder characterized by the growth of endometrial gland and stroma outside the uterus, causes several symptoms such as dysmenorrhea, hypermenorrhea, and chronic abdominal pain.
Akihiko Wakatsuki +5 more
doaj +1 more source
Acta Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 6, Page 969-971, June 2026.
wiley +2 more sources
The Miniature Meta‐Nano‐Channel (MNC) field‐effect bioFET is designed for sensing the electrostatic perturbation between estriol and its antibody toward a potential point‐of‐care device. The MNC bioFET is currently employed for real‐time, specific, and label‐free detection of estriol in 0.5 µL drops of diluted plasma with a limit‐of‐detection of 1 fg ...
Shubham Babbar +16 more
wiley +1 more source
A novel estetrol-containing combined oral contraceptive:European expert panel review
PURPOSE: Despite considerable advances in recently developed combined oral contraceptives (COCs), resulting in lower rates of adverse events while maintaining contraceptive efficacy, there is interest in further innovation.MATERIALS AND METHODS: Estetrol
Ski, Robert Spaczy +27 more
core +1 more source
Estetrol (E4) is a natural human estrogen present at high concentrations during pregnancy. Due to its high oral bioavailability and long plasma half-life, E4 is particularly suitable for therapeutic applications.
Maria Silvia eGiretti +10 more
doaj +1 more source
Postpartum contraception: A matter of guidelines
Abstract The postpartum period is the perfect time to access family planning services. WHO guidelines contraindicate combined hormonal contraceptives postpartum in breastfeeding patients between 6 weeks and 6 months after delivery (Medical Eligibility Criteria category 3).
Giovanni Grandi +3 more
wiley +1 more source
One of the most controversial issues of modern gynecology is the study of the effect of combined oral contraceptives (COCs) on the endocrine-metabolic profile. Unfortunately, there are still hormonophobic prejudices in society about the adverse impact of
Mekan R. Orazov +2 more
doaj +1 more source
A Dose-Escalating Study With the Fetal Estrogen Estetrol in Healthy Men
Context Luteinizing hormone–releasing hormone (LHRH) agonists have replaced estrogens for endocrine treatment of advanced prostate cancer (PC) because of cardiovascular side effects.
Cornelis Kluft +7 more
core +1 more source
Iron deficiency states, including latent iron deficiency and iron deficiency anemia, remain one of the main comorbidities in the world’s female population.
Mekan R. Orazov +3 more
doaj +1 more source
Fetal Estetrol (E4) Inhibits Growth Hormone (GH) Signal Transduction in Breast Cancer Cell Lines
Objective: Inhibition of GH signaling has been associated with increased longevity and cancer resistance. As the fetal estrogen estetrol was also linked to longevity and cancer resistance, we hypothesized that these effects of estetrol are mediated by ...
Biochemisch laboratorium +9 more
core

